Zen Graphene Solutions logo imageZentek Ltd (formerly known as ZEN Graphene Solutions and before that, Zenyatta Ventures) is a mineral exploration and development company based in Ontario, Canada. Zentek is developing the Albany Graphite Deposit – a rare hydrothermal graphite deposit with the potential to produce a natural, high-purity graphite that may compete in high-technology markets traditionally reserved for synthetic graphite.

The company's high crystallinity graphite can be upgraded without the use of aggressive acid (HF) or high temperature thermal treatment. Zentek has developed an environmentally friendly metallurgical process flowsheet that consists of grinding, flotation and caustic treatment using sodium hydroxide. The company states that it has been able to achieve an extraordinary carbon purity result of >99.9 percent in bench-scale tests, using this proprietary and environmentally friendly purification process.

According to Zentek, current end uses for its graphene materials include composites (concrete, rubber and plastics), energy storage and environmental applications but many more are under development.

Company Address: 
1224 Amber Drive
Thunder Bay, ON P7B 6M5
Canada

The latest ZEN Graphene news:

Zentek announces USD$15,900,000 Bought Deal Public Offering and USD$9.9 Million Non-Brokered Private Placement

Zentek (formerly called Zen Graphene Solutions) has announced that it has entered into an agreement to raise CAD$20 million (around USD$15,928,000).



In addition, the Company intends to complete a concurrent non-brokered private placement for gross proceeds of approximately CAD$12.5 million (around USD$9,954,000).

Graphene oxide could improve aircraft fuel

A team of researchers at UBC Okanagan (UBCO), studying the burning rate of nanomaterials in liquid fuels, believe they have created a recipe for clean-burning, power-boosting aircraft fuel.

A droplet of fuel mixed with nanomaterials is ignited during an experiment in UBCO’s lab imageA droplet of fuel mixed with nanomaterials is ignited during an experiment in UBCO’s Combustion for Propulsion and Power Lab. Image credit: UBCO

The team is investigating the combustion characteristics of microscopic graphene oxide inside fuel. Their experiment measures the ignition delay, burn rate and speed by which the graphene particles and fuel separate into smaller particles. “Working with our industry partner, ZEN Graphene Solutions, we are assessing how the burn rate of this mixture can potentially improve its combustion properties,” explains lead author and doctoral student Sepehr Mosadegh.

Zen Graphene Solutions gets Health Canada approval and reports first revenue from shipment of graphene coating

Months after Health Canada deemed graphene-enhanced face masks as a "potential health hazard", ZEN Graphene Solutions announced receiving an approval from Health Canada for its ZENGuard™ disposable face mask with biocidal coating and is rated at an ASTM Level 3. An extensive review process took place, after which Health Canada validated ZENGuard™-enhanced surgical masks as 'safe for use by Canadians'.

In addition, ZEN Graphene Solutions also announced that it has delivered and generated revenue from its first shipment of ZENGuard antimicrobial coating to Trebor Rx. This first commercial shipment was enabled by a successful ramp up from bench scale production to pilot scale capacity, which currently exceeds the amount needed to coat 30 million masks per month. The company also reports that the engineering work on its industrial plant with an estimated capacity to coat the equivalent of 800 million masks per month is in the procurement stage. ZEN expects the build out and commissioning of the plant to be completed during the fourth quarter.

ZEN Graphene Solutions finalizes definitive commercial agreement with Trebor Rx

ZEN Graphene Solutions recently announced the signing of a definitive commercial agreement with Trebor Rx for the manufacturing of ZENGuard™-enhanced personal protective equipment. The agreement includes surgical masks, filters for Trebor’s patent pending Pro+ mask, nitrile gloves and other potential products.

Greg Fenton, Zen's CEO, commented: ”After working closely with George Irwin and the Trebor team over the last year, we have developed an excellent working relationship and are eager to launch our first product together, the Trebor Rx surgical mask with ZENGuard™ technology delivering over 99.99% bacterial and viral filtration efficiency. This is a significant commercial success for both our organizations, but more importantly, it brings a new option to healthcare employees and others in higher risk settings that wish to significantly enhance the bacterial and viral filtration efficiency compared to a typical, disposable ASTM level 3 mask.”

Tags: